To confirm the induction of apoptosis in uterine sarcoma cells by combined SAHA/TRAIL treatment with a more specific marker, cleavage of PARP-1 was demonstrated by immunoblotting. This evidence concerns the gene TNFSF10 and uterine corpus sarcoma.